| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | CLOV | Stock Options (right to buy) | 18 Jul 2022 | Class B Common Stock | 79,349 | $1.26 | Direct | F1, F2 | ||||||
| holding | CLOV | Stock Options (right to buy) | 18 Jul 2022 | Class B Common Stock | 362,252 | $1.67 | Direct | F2, F3 | ||||||
| holding | CLOV | Stock Options (right to buy) | 18 Jul 2022 | Class B Common Stock | 60,318 | $3.66 | Direct | F2, F4 |
| Id | Content |
|---|---|
| F1 | Received in connection with an August 10, 2016, grant covering 229,349 shares of the Company's Class B common stock. 150,000 shares subject to this grant were exercised and sold prior to the date hereof, and the remaining 79,349 shares subject to the grant are currently vested and exercisable. |
| F2 | The Class B Common Stock will be convertible into shares of Class A Common Stock on a one-to-one basis at the option of the holders of the Class B Common Stock at any time upon written notice to the Issuer. In addition, the Class B Common Stock will automatically convert into shares of Class A Common Stock immediately prior to the close of business on the earliest to occur of certain events specified in the Issuer's Amended and Restated Certificate of Incorporation. |
| F3 | Received in connection with a September 13, 2017, grant covering 362,252 shares of the Company's Class B common stock. 100% of the shares subject to this grant are currently vested and exercisable. |
| F4 | Received in connection with a June 29, 2020, grant covering 103,302 shares of the Company's Class B common stock. 43,085 shares subject to this grant were canceled prior to the date hereof, and the remaining 60,318 shares subject to the grant are currently vested and exercisable. |
Exhibit List: Exhibit 24-Power of Attorney